Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

In the whirlpool of broken narratives, post-truth dissonances, and chaos, every inch of newspaper space taken up by absurdity is wasted space.

Discover the unique tradition of the Konda Reddi tribe in Andhra Pradesh, celebrating summer with bamboo shoots and fish.

Congress leader Rahul Gandhi on Friday (February 14, 2025) accused Prime Minister Narendra Modi of “covering up” the alleged ...

World leaders, tech giants, and experts gather at a Paris summit to debate AI’s future, but concerns grow over regulatory ...

Teenagers tackled the big issues in South Australia as they took the places of the state’s politicians in Parliament House.

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.

Jinxin Technology Holding Company (the "Company") , an innovative provider of digital-content products and services in China, today announced an in-depth strategic partnership with Tencent Cloud and ...

Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on GERN stock, giving a Buy rating yesterday.Invest with ...

Teenager Tali Pipe is passionate about giving Indigenous young people opportunities so they can reach their potential.

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...